Related Experiment Video
Updated: Jul 5, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Applying and Improving a Publicly Available Medication NER Pipeline in a Clinical Cancer EMR
Meg Stevens1, Georgina Kennedy1,2,3, Timothy Churches1,2
1University of New South Wales, Sydney Australia.
Abstract:
Clinical NLP can be applied to extract medication information from free-text notes in EMRs, using NER pipelines. Publicly available annotated data for clinical NLP are scarce, and research annotation budgets are often low. Fine-tuning pre-trained pipelines containing a Transformer layer can produce quality results with relatively small training corpora. We examine the transferability of a publicly available, pre-trained NER pipeline with a Transformer layer for medication targets. The pipeline performs poorly when directly validated but achieves an F1-score of 92% for drug names after fine-tuning with 1,565 annotated samples from a clinical cancer EMR - highlighting the benefits of the Transformer architecture in this setting. Performance was largely influenced by inconsistent annotation - reinforcing the need for innovative annotation processes in clinical NLP applications.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Methods of Documentation VII: EMR
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...

